M. Dervichian

Mutations in the MEFV gene in a large series of patients with a clinical diagnosis of familial Mediterranean fever.

C. Cazeneuve, S. Amselem, C. Dodé, 2000, American journal of medical genetics.

Clinical versus genetic diagnosis of familial Mediterranean fever.

C. Cazeneuve, S. Amselem, C. Dodé, 2000, QJM : monthly journal of the Association of Physicians.

Colchicine disposition in human leukocytes after single and multiple oral administration

P. Hung, E. Niel, J. Wautier, 1993, Clinical pharmacology and therapeutics.

High Risk of Anal and Rectal Cancer in Patients With Anal and/or Perianal Crohn’s Disease

J. Hugot, B. Bonaz, J. Rey, 2017, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Evidence for circulating fibrin in familial Mediterranean fever.

M. Mosesson, D. Cattan, M. Dervichian, 1982, The Journal of laboratory and clinical medicine.

METARAMINOL PROVOCATION TEST FOR FAMILIAL MEDITERRANEAN FEVER

D. Cattan, M. Dervichian, Y. Nurit, 1984, The Lancet.

MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications.

J. Kouyoumdjian, C. Cazeneuve, S. Amselem, 1999, American journal of human genetics.

[Familial Mediterranean fever].

D. Cattan, M. Dervichian, 2002, La Revue du praticien.

Colchicine concentration in leukocytes of patients with familial Mediterranean fever.

E. Niel, O. Chappey, J. Scherrmann, 1994, British journal of clinical pharmacology.

MEFV mutations and phenotype-genotype correlations in North African Jews and Armenians with familial Mediterranean fever.

I. Touitou, M. Thomas, C. Dodé, 2001, The Israel Medical Association journal : IMAJ.

Plasma dopamine beta-hydroxylase activity in familial Mediterranean fever.

J. Launay, D. Cattan, M. Dervichian, 1992, Israel journal of medical sciences.